A randomised phase II/III trial of induction chemotherapy followed
by
Continuous Hyperfractionated Accelerated Radiotherapy (CHART)
versus CHART alone in patients with inoperable non-small cell lung
cancer.

For more detail on A to D above see Radiotherapy QA Protocol